These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 7189187)

  • 1. Unusual reaction to intramuscular sulfone in two leprosy patients in Malaysia.
    Laing AB
    Int J Lepr Other Mycobact Dis; 1980 Mar; 48(1):70. PubMed ID: 7189187
    [No Abstract]   [Full Text] [Related]  

  • 2. Intramuscular injection of dapsone in therapy for leprosy: a new approach.
    Modderman ES; Huikeshoven H; Zuidema J; Leiker DL; Merkus FW
    Int J Clin Pharmacol Ther Toxicol; 1982 Feb; 20(2):51-6. PubMed ID: 7061179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oily injections of dapsone; an acceptable form of treatment?
    Warndorff van Diepen T
    Lepr Rev; 1986 Mar; 57(1):70-2. PubMed ID: 3702583
    [No Abstract]   [Full Text] [Related]  

  • 4. Sex differences in the absorption of dapsone after intramuscular injection.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):359-65. PubMed ID: 6685698
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Streptomycin combined with sulfones in the treatment of relapsed lepromatous leprosy.
    Hastings RC; Trautman JR
    Int J Lepr Other Mycobact Dis; 1968; 36(1):45-51. PubMed ID: 5689649
    [No Abstract]   [Full Text] [Related]  

  • 6. Mortality due to dapsone hypersensitivity syndrome complicating multi-drug therapy for leprosy in Nepal.
    Pandey B; Shrestha K; Lewis J; Hawksworth RA; Walker SL
    Trop Doct; 2007 Jul; 37(3):162-3. PubMed ID: 17716505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dapsone levels after oral therapy and weekly oily injections in Ethiopian leprosy patients.
    Modderman ES; Merkus FW; Zuidema J; Hilbers HW; Warndorff T
    Int J Lepr Other Mycobact Dis; 1983 Jun; 51(2):191-6. PubMed ID: 6684645
    [No Abstract]   [Full Text] [Related]  

  • 8. A retrospective study of the effect of modified multi-drug therapy in Nepali leprosy patients following the development of adverse effects due to dapsone.
    Sapkota BR; Shrestha K; Pandey B; Walker SL
    Lepr Rev; 2008 Dec; 79(4):425-8. PubMed ID: 19274989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on sulfone resistance in leprosy. I. Detection of cases.
    Pettit JH; Rees RJ; Ridley DS
    Int J Lepr Other Mycobact Dis; 1966; 34(4):375-90. PubMed ID: 6006069
    [No Abstract]   [Full Text] [Related]  

  • 10. Acute Generalized Exanthematous Pustulosis (AGEP) due to dapsone in a patient with leprosy.
    Narasimharao P; Pratap DV; Suneetha S
    Lepr Rev; 2009 Mar; 80(1):81-4. PubMed ID: 19472855
    [No Abstract]   [Full Text] [Related]  

  • 11. Incidence of anemia in leprosy patients treated with dapsone.
    Puavilai S; Chutha S; Polnikorn N; Timpatanapong P; Tasanapradit P; Charuwichitratana S; Boonthanom A; Wongwaisayawan H
    J Med Assoc Thai; 1984 Jul; 67(7):404-7. PubMed ID: 6512448
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypersensitivity reaction to dapsone: report from Malaysia.
    Mohamed KN
    Lepr Rev; 1984 Dec; 55(4):385-9. PubMed ID: 6527602
    [No Abstract]   [Full Text] [Related]  

  • 13. Rifampin 1200 mg once monthly together with daily Lamprene and dapsone in treatment of refactory patients with lepromatous leprosy.
    Paul S; Rose ET
    Int J Lepr Other Mycobact Dis; 1981 Sep; 49(3):342-3. PubMed ID: 7198625
    [No Abstract]   [Full Text] [Related]  

  • 14. Dapsone haemolysis in leprosy. A preliminary report.
    Menezes S; Rege VL; Sehgal VN
    Lepr India; 1981 Jan; 53(1):63-9. PubMed ID: 7218764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemotherapeutic trials in leprosy. 4. Dapsone (DDS) in low dosage in the treatment of lepromatous leprosy. A demonstration pilot study.
    Pettit JH; Rees RJ
    Int J Lepr Other Mycobact Dis; 1967; 35(2):140-8. PubMed ID: 5338958
    [No Abstract]   [Full Text] [Related]  

  • 16. Dapsone-induced methemoglobinemia in leprosy patients.
    Kaur I; Mehta M; Agnihotri N; Dogra S; Ganguly NK
    Int J Lepr Other Mycobact Dis; 2001 Sep; 69(3):247-9. PubMed ID: 11875770
    [No Abstract]   [Full Text] [Related]  

  • 17. Dapsone induced psychosis.
    Balkrishna ; Bhatia MS
    J Indian Med Assoc; 1989 May; 87(5):120-1. PubMed ID: 2600436
    [No Abstract]   [Full Text] [Related]  

  • 18. [Vitamin E as protective agent against hemolysis in leprosy patients under dapsone treatment].
    Lardo MM; Díaz NB; Artaza JR; Carbia CD; Nazer R; Valdez R
    Medicina (B Aires); 1997; 57(2):150-4. PubMed ID: 9532824
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dapsone syndrome in Goa.
    Rege VL; Shukla P; Mascarenhas MF
    Indian J Lepr; 1994; 66(1):59-64. PubMed ID: 7983393
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy.
    Jing Z; Zhang R; Zhou D; Chen J
    Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.